Data-driven precision offers a path to elimination of Kala-azar disease
Cases of kala-azar, also known as visceral leishmaniasis, have spiked in Kenya, from 1,575 in 2024 to 3,577 in 2025, according to the health ministry.
According to the area MOH officer, Dr Eliud Pariken, the disease presents with symptoms including prolonged high fever, drastic weight loss, and severe anaemia, and can be fatal if untreated.